NLRP3 and Insulin resistance: Taken together, our results suggest that pharmacological inhibition of the NLRP3 inflammasome enhances GLUT4myc-eGFP translocation onto the cell surface of skeletal muscles from animals with insulin resistance, which could directly improve the glucose transport in this pathological condition.